Resistance of Plasmodium falciparum.
D000349:Africa; D000818:Animals; D000962:Antimalarials / Q000494:pharmacology*; D001208:Asia; D002738:Chloroquine / Q000378:metabolism; D004247:DNA / Q000378:metabolism; D004351:Drug Resistance; D004357:Drug Synergism; D006427:Hemin / Q000378:metabolism; D008288:Malaria / Q000188:drug therapy; D010963:Plasmodium falciparum / Q000187:drug effects* / Q000235:genetics / Q000254:growth & development / Q000378:metabolism; D011319:Primaquine / Q000494:pharmacology; D002727:Proguanil / Q000494:pharmacology; D011739:Pyrimethamine / Q000494:pharmacology; D011796:Quinacrine / Q000494:pharmacology; D011803:Quinine / Q000494:pharmacology; D011804:Quinolines / Q000494:pharmacology; D012313:RNA / Q000378:metabolism; D012106:Research; D013020:South America
D000962:Antimalarials; D011804:Quinolines; D012313:RNA; D006427:Hemin; D002738:Chloroquine; D004247:DNA; D011803:Quinine; D011796:Quinacrine; D011319:Primaquine; D002727:Proguanil; D011739:Pyrimethamine